Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 154-161

  Chen, Xin ^a,b   Bäumel, Monika ^b   Männel, Daniela N ^b   Howard, O M Zack ^c   Oppenheim, Joost J ^c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SEPSIS;

EID: 34250864955     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.154     Document Type: Article

References (34)

1. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756.
2. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-357.
3. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148: 2724-2730.
4. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock: a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201.
5. Sterns, T., N. Pollak, B. Echtenacher, and D. N. Mannel. 2005. Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect. Immun. 73: 4905-4912.
6. Zganiacz, A., M. Santosuosso, J. Wang, T. Yang, L. Chen, M. Anzulovic, S. Alexander, B. Gicquel, Y. Wan, J. Bramson, M. Inman, and Z. Xing. 2004. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113: 401-413.
7. Zakharova, M., and H. K. Ziegler. 2005. Paradoxical anti-inflammatory actions of TNF-α: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 175: 5024-5033.
8. Cope, A. P., R. S. Liblau, X. D. Yang, M. Congia, C. Laudanna, R. D. Schreiber, L. Probert, G. Kollias, and H. O. McDevitt. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185: 1573-1584.
9. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16: 81-88.
10. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
11. + human thymocytes. J. Exp. Med. 196: 379-387.
12. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200: 277-285.
13. + T cells in patients with active rheumatoid arthritis is reduced by infliximab. Ann. NY Acad. Sci. 1051: 506-514.
14. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99: 12287-12292.
15. hi T regulatory cells. Blood 108: 253-261.
16. Kim, E. Y., and H. S. Teh. 2001. TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 167: 6812-6820.
17. Djouad, F., V. Fritz, F. Apparailly, P. Louis-Plence, C. Bony, J. Sany, C. Jorgensen, and D. Noel. 2005. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis Rheum. 52: 1595-1603.
18. Cope, A. P. 1998. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10: 669-676.
19. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563.
20. Carpentier, I., B. Coornaert, and R. Beyaert. 2004. Function and regulation of tumor necrosis factor type 2. Curr. Med. Chem. 11: 2205-2212.
21. Kim, E. Y., J. J. Priatel, S. J. Teh, and H. S. Teh. 2006. TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 176: 1026-1035.
22. - T cells to dexamethasone-induced cell death. Eur. J. Immunol. 34: 859-869.
23. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
24. Ebach, D. R., T. E. Riehl, and W. F. Stenson. 2005. Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture. Shock 23: 311-318.
25. + regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31: 2068-2071.
26. - lymphocytes. Crit. Care Med. 32: 2329-2331.
27. Sutmuller, R. P., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116: 485-494.
28. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053.
29. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098.
30. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193: 427-434.
31. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
32. Docke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3: 678-681.
33. + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J. Immunol. 174: 7141-7146.
34. Brennan, F. M., A. D. Foey, and M. Feldmann. 2006. The importance of T cell interactions with macrophages in rheumatoid cytokine production. Curr. Top. Microbiol. Immunol. 305: 177-194.